A. Ogrodniczak

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

A. Jakubowska, J. Lubiński, C. Cybulski, 2022, Hereditary cancer in clinical practice.

Rare germline copy number variants (CNVs) and breast cancer risk

Jack A. Taylor, S. Cross, M. Beckmann, 2022, Communications Biology.